In humans the biliary excretion of trifluoroacetic acid, the major halothane metabolite, has not been studied. We investigated the biliary excretion of trifluoroacetic acid in two infants agedjive months and two months following halothane anaesthesia for the operation of choledocholithotomy. Bile, urine and faeces were collected continuously for jive days after operation and trifluoroacetic acid excretion measured. Estimates of halothane uptake, daily bile flow and the proportion of daily bile flow collected via the T-tube drainage catheter were subject to percentage errors possibly as large as 50%. Of the total trifluoroacetic acid producedfrom halothane metabolism, it was estimated that 17% in thejive-month-old infant and 20% in the two-month infant was excreted in bile. In the jive-month-old infant where approximately 80% of the bile produced entered the duodenum in the normal way, no faecal trifluoroacetic acid was detected suggesting an enterohepatic circulation for this metabolite.
Several studies l -3 have found that from 10-18% of absorbed halothane is excreted in urine as trifluoroacetic acid (TFA). In humans the biliary excretion of TF A has not been investigated. Our study in two infants was performed, first to assess whether TF A is excreted in bile and second to ascertain whether it has an enterohepatic circulation.
PATIENTS AND METHODS

Patient 1
This patient was a 7.3 kg male infant of five months who presented to hospital with a two-week history of increasing jaundice. A disida scan and liver ultrasound suggested a diagnosis of gallstones and biliary sludge obstructing the common bile duct. At operation he had a liver biopsy, cholecystectomy and choledocholithotomy with removal of gallstones and biliary mud. AT-tube drain was left in the common bile duct for five days after operation. Halothane 2% was administered for ten minutes at induction and halothane 0.5% was administered for 170 minutes during anaesthetic maintenance. Patient uptake of halothane was estimated using the data from Wark, Earl, Chau and Overton. 3 All bile, urine and faeces were collected for five days. Bile and urine collections were measured and then stored at -4°C until analysed for TFA. Urine was collected by means of a Coloplast baby urine collector (Coloplast International, Espergaerde, Denmark). Pre-and postoperative liver function tests are shown in Table 1 .
Patient 2
This patient was a 4.0 kg female infant of two months in whom jaundice was noted three weeks before admission. A disida scan and liver ultrasound showed stones in the common bile duct. At laparotomy a liver biopsy, cholecystectomy, operative cholangiogram and choledocholithotomy were performed and biliary mud removed. A T-tube was left in the common bile duct. Halothane 0.5% was administered for 135 minutes during anaesthetic maintenance. All urine, bile and faeces were collected daily for five days and stored at -4°C until analysed for TFA. Liver function tests taken on admission and again six days after operation are shown in Table 1 .
Laboratory methods
Serum bilirubin concentrations were determined using the method of lendrassick and Grof. Serum concentrations of AST, ALT, GGT and SAP were determined using an IL Multistat III auto analyser. Normal laboratory values of liver function tests used are given in Table 2 . Bile, urine, and stool samples were analysed for TFA using a modification of the method of Maiorino, Gandolfi and Sipes. 4
RESULTS
Patient 1
Using a halothane uptake figure of 250 mglkgl percent halothane/hour, it was estimated that this patient absorbed 16.2 mmol of halothane. Faeces obtained after operation were bile stained, indicating that some bile passed around the drainage tube into the duodenum. Using the data of Shaffer, Broasch and Smal1 5 it was assumed that bile flow was 20 mllkglday.
Of the total daily bile production 20% was collected via the T-tube drain and 80% entered the duodenum in the normal way. From bile concentration measurements and estimated bile volumes the daily excretion of biliary TF A was calculated. Results of TF A measurement in urine and bile are shown in Table 3 . Of the absorbed halothane 1.7% was excreted in bile as TF A. This constitutes 1 7% of the halothane metabolized to TFA. NoTFA was detected in the faeces. Taking into account the sensitivity of the assay this means that less than 5 ~mol ofTF A was present in the total stool sample of 43.7 g.
Patient 2
Using a similar uptake figure to that used in patient 1, it was estimated that 5.7 mmol of halothane was absorbed. Results of bile and urine collections are shown in Table 4 . The stools passed after operation were a cream colour indicating that all bile had been collected via the T-tube drain. No TF A was detected in the stool. It was estimated that 1.5% of absorbed halothane was excreted in bile as TF A. Of all TF A produced from halothane metabolism, 21 % was excreted in the bile. DISCUSSION Cascorbi, Blake and Helrich 6 in 1970 injected intravenous 14C-halothane into a nonanaesthetised adult patient and collected faeces for two days. By measuring stool radioactivity levels they found that 0.036% of the injected dose of halothane was excreted in the faeces. In 1972
Topham and Longshaw 7 studied two dogs and three cats by collecting bile for four hours following halothane anaesthesia. A quantitative assessment was not made but these authors found that although nonvolatile radioactivity was excreted into the bile, little radioactivity was found in faeces. They suggested that there could be an entero-hepatic recirculation for the nonvolatile radioactive metabolites of halothane.
In our two infants we estimated that 17% and 21 % of the TF A produced from halothane metabolism was excreted in bile. In patient 1, where approximately 80% of bile production entered the duodenum, no TF A could be detected Halothane absorption. It was assumed that halothane was absorbed at a rate of 250 mglkg/percent inspired halothane concentration 3 giving a halothane uptake figure of 5.7 mmol.
in the stool confirming an enterohepatic circulation for TF A. There were several possible sources of error in the study. Halothane was assumed to be absorbed at a rate of 250 mg/kg/percent halothane/ hour 3 and in patient 1, bile production was assumed to be 20 mlIkg/day.4 Urine and bile collections were thought to be complete although it is possible that small amounts could have been lost. Percentage errors involved in the estimates of halothane uptake, daily bile flow and the proportion of daily bile flow collected via the T -tube drainage catheter could have been as much as 50%. Although these sources of error are large, they do not influence the qualitative conclusions to be drawn from the study. The assay for TF A used in the study was a modified and improved method of Moiorino, Gandolfi and Sipes 4 which has been the reference method for measuring TF A in studies of halothane metabolism since it was described in 1980. The assay procedure has an extraction step involving concentrated sulphuric acid and any amide or esterified conjugates of TF A would be hydrolysed to free TF A. Some or all of the TF A produced from halothane metabolism may be present in a very wide and heterogeneous variety of trifluoroacetyl ester and amide compounds which are measured'by the Moiorino assay as part of the total TF A. We plan in a subsequent investigation to develop a measurement technique which distinguishes free and bound TF A.
The conclusion from the study is that approximately 80% of all TF A produced from the hepatic metabolism of halothane is released into the serum to be excreted in urine. The remaining 20% ofTFA is excreted in bile, reabsorbed from the small bowel into the serum with subsequent urine excretion. This enterohepatic circulation for TF A may explain its prolonged excretion and why traces of TF A are found in urine for up to 21 days following halothane anaesthesia. 6 
